Lycopene in Treating Patients With Metastatic Prostate Cancer
Study Information
Alliance Study ID: NCCTG-N0351
NCT Study ID (ClinicalTrials.gov): NCT00068731
Disease or Cancer Type: Prostate Cancer
Alliance Study Chair: Aminah Jatoi, MD
Status: COMPLETED
Study Description
RATIONALE: Lycopene, a substance found in tomatoes, may lower prostate-specific antigen (PSA) levels and slow or prevent the development of prostate cancer.
PURPOSE: Phase II trial to study the effectiveness of lycopene in treating patients who have asymptomatic metastatic prostate cancer and a rising PSA level.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information